tradingkey.logo
tradingkey.logo
Search

Procept Biorobotics Corp

PRCT
Add to Watchlist
22.370USD
+1.750+8.49%
Close 11-09 16:00(ET)
1.28BMarket Cap
LossP/E TTM

Procept Biorobotics Corp (PRCT) Stock Price Target & Forecast

Analyst Rating

Based on 15 analysts giving stock ratings to Procept Biorobotics Corp in the past month.

Hold
1 Strong Buy
4 Buy
9 Hold
1 Sell
0 Strong Sell
Target Price
24.571USD+27.98%

PRCT Analyst Recommendation Trends

In the current month, PRCT has received 4 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. PRCT average Analyst price target in the last month is 24.571.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
1
1
2
2
3
3
3
3
Buy
4
4
5
8
7
7
7
7
Hold
9
9
7
5
4
4
4
3
Strong Sell
0
0
0
0
0
0
0
0
Sell
1
1
1
1
1
1
1
1
Total
15
15
15
16
15
15
15
14

PRCT Analyst Rating for Peer Comparison

Updated: Nov 5, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21

Financial Forecasting

Based on analysts' estimates, PRCT EPS is projected to reach -0.250 in FY2026Q4, following reported EPS of -0.463 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.56
-0.46
-0.39
-0.25
-0.40
Actual
-0.56
-0.47
-0.46
--
--
Surprise
-0.62%
-3.01%
-19.48%
--
--

FAQs

What is Procept Biorobotics Corp's expected revenue for the next quarter?

Procept Biorobotics Corp's expected revenue is 117.72M.

What is Procept Biorobotics Corp's price target?

Analysts forecast that Procept Biorobotics Corp's price target is USD 24.64, with the highest forecast at USD 51.00 and the lowest forecast at USD 16.00.

How have Procept Biorobotics CorpPRCT's recent earnings per share performed?

The market expectation was USD -0.46, while Procept Biorobotics CorpPRCT's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.25.

What is the analyst rating for Procept Biorobotics Corp?

Based on the ratings of Procept Biorobotics Corp's stock from 15 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.